Skip to main navigation Skip to search Skip to main content

Silica-based nanoparticles for therapeutic protein delivery

  • Meihua Yu
  • , Zhengying Gu
  • , Thomas Ottewell
  • , Chengzhong Yu*
  • *Corresponding author for this work
  • University of Queensland
  • University of Victoria BC

Research output: Contribution to journalReview articlepeer-review

Abstract

Nowadays, protein therapeutics receive unprecedented recognition for their great potential in the treatment of a variety of diseases. The efficacy of native therapeutic proteins is limited by their intrinsic poor stability and cell membrane permeability. Tremendous efforts have been devoted to developing efficient protein delivery systems. The past decade has witnessed the development and successful application of silica-based nanoparticles (SiNPs) as therapeutic protein carriers. This review focuses on recent advances in SiNPs in therapeutic protein delivery for disease and cancer treatment. The limitations of current studies and the room for improvement of SiNPs in therapeutic protein delivery are discussed.

Original languageEnglish
Pages (from-to)3241-3252
Number of pages12
JournalJournal of Materials Chemistry B
Volume5
Issue number18
DOIs
StatePublished - 2017
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Silica-based nanoparticles for therapeutic protein delivery'. Together they form a unique fingerprint.

Cite this